Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
103 "stomach"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Review
Article image
A standardized pathology report for gastric cancer: 2nd edition
Young Soo Park, Myeong-Cherl Kook, Baek-hui Kim, Hye Seung Lee, Dong-Wook Kang, Mi-Jin Gu, Ok Ran Shin, Younghee Choi, Wonae Lee, Hyunki Kim, In Hye Song, Kyoung-Mee Kim, Hee Sung Kim, Guhyun Kang, Do Youn Park, So-Young Jin, Joon Mee Kim, Yoon Jung Choi, Hee Kyung Chang, Soomin Ahn, Mee Soo Chang, Song-Hee Han, Yoonjin Kwak, An Na Seo, Sung Hak Lee, Mee-Yon Cho
J Pathol Transl Med. 2023;57(1):1-27.   Published online January 15, 2023
DOI: https://doi.org/10.4132/jptm.2022.12.23
  • 9,739 View
  • 1,044 Download
  • 8 Web of Science
  • 8 Crossref
AbstractAbstract PDFSupplementary Material
The first edition of ‘A Standardized Pathology Report for Gastric Cancer’ was initiated by the Gastrointestinal Pathology Study Group of the Korean Society of Pathologists and published 17 years ago. Since then, significant advances have been made in the pathologic diagnosis, molecular genetics, and management of gastric cancer (GC). To reflect those changes, a committee for publishing a second edition of the report was formed within the Gastrointestinal Pathology Study Group of the Korean Society of Pathologists. This second edition consists of two parts: standard data elements and conditional data elements. The standard data elements contain the basic pathologic findings and items necessary to predict the prognosis of GC patients, and they are adequate for routine surgical pathology service. Other diagnostic and prognostic factors relevant to adjuvant therapy, including molecular biomarkers, are classified as conditional data elements to allow each pathologist to selectively choose items appropriate to the environment in their institution. We trust that the standardized pathology report will be helpful for GC diagnosis and facilitate large-scale multidisciplinary collaborative studies.

Citations

Citations to this article as recorded by  
  • Genomic and Transcriptomic Characterization of Gastric Cancer with Bone Metastasis
    Sujin Oh, Soo Kyung Nam, Keun-Wook Lee, Hye Seung Lee, Yujun Park, Yoonjin Kwak, Kyu Sang Lee, Ji-Won Kim, Jin Won Kim, Minsu Kang, Young Suk Park, Sang-Hoon Ahn, Yun-Suhk Suh, Do Joong Park, Hyung Ho Kim
    Cancer Research and Treatment.2024; 56(1): 219.     CrossRef
  • Microscopic tumor mapping of post-neoadjuvant therapy pancreatic cancer specimens to predict post-surgical recurrence: A prospective cohort study
    Yeshong Park, Yeon Bi Han, Jinju Kim, MeeYoung Kang, Boram Lee, Eun Sung Ahn, Saemi Han, Haeryoung Kim, Hee-Young Na, Ho-Seong Han, Yoo-Seok Yoon
    Pancreatology.2024; 24(4): 562.     CrossRef
  • Effect of Neoadjuvant Chemotherapy on Tumor-Infiltrating Lymphocytes in Resectable Gastric Cancer: Analysis from a Western Academic Center
    Elliott J. Yee, Danielle Gilbert, Jeffrey Kaplan, Sachin Wani, Sunnie S. Kim, Martin D. McCarter, Camille L. Stewart
    Cancers.2024; 16(7): 1428.     CrossRef
  • Interpretation of PD-L1 expression in gastric cancer: summary of a consensus meeting of Korean gastrointestinal pathologists
    Soomin Ahn, Yoonjin Kwak, Gui Young Kwon, Kyoung-Mee Kim, Moonsik Kim, Hyunki Kim, Young Soo Park, Hyeon Jeong Oh, Kyoungyul Lee, Sung Hak Lee, Hye Seung Lee
    Journal of Pathology and Translational Medicine.2024; 58(3): 103.     CrossRef
  • Expression of claudin 18.2 in poorly cohesive carcinoma and its association with clinicopathologic parameters in East Asian patients
    Moonsik Kim, Byung Woog Kang, Jihyun Park, Jin Ho Baek, Jong Gwang Kim
    Pathology - Research and Practice.2024; 263: 155628.     CrossRef
  • Pathological Interpretation of Gastric Tumors in Endoscopic Submucosal Dissection
    Jung Yeon Kim
    Journal of Digestive Cancer Research.2023; 11(1): 15.     CrossRef
  • Histopathology of Gastric Cancer
    Baek-hui Kim, Sung Hak Lee
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2023; 23(2): 143.     CrossRef
  • Endoscopic submucosal dissection hands-on training with artificial mucosal layer EndoGEL
    Tae-Se Kim, Jun Haeng Lee
    Journal of Innovative Medical Technology.2023; 1(1): 5.     CrossRef
Case Study
Article image
Heterotopic mesenteric ossification: a report of two cases
Hisham F. Bahmad, Olga Lopez, Tyson Sutherland, Marisa Vinas, Kfir Ben-David, Lydia Howard, Robert Poppiti, Sarah Alghamdi
J Pathol Transl Med. 2022;56(5):294-300.   Published online September 13, 2022
DOI: https://doi.org/10.4132/jptm.2022.07.23
  • 2,550 View
  • 84 Download
  • 2 Crossref
AbstractAbstract PDF
Heterotopic mesenteric ossification (HMO) is abnormal bone formation in tissues which usually do not undergo ossification. There are approximately 75 cases reported worldwide. We present two cases of HMO. The first case is that of a 39-year-old man who presented with abdominal pain and a computerized tomography scan of the abdomen and pelvis revealed an apple core lesion resulting in small bowel obstruction. The second case is that of a 36-year-old woman who presented 2 months after undergoing robotic gastric sleeve resection complaining of weakness and emesis. An esophagogram revealed kinking at the distal esophagus. Surgical resection was performed in both, yielding the diagnosis of HMO. There are various theories as to the pathophysiology of HMO, but no clearly defined mechanism has been established. Management should be conservative whenever possible to prevent further ossification with subsequent surgical intervention.

Citations

Citations to this article as recorded by  
  • Fatal Moans and Bones in Crohn's
    Joyce Opara, Heather Jarrell, Nicole R. Jackson
    American Journal of Forensic Medicine & Pathology.2024;[Epub]     CrossRef
  • Heterotopic mesenteric ossification caused by trauma: A case report
    Bi-Fang Zhang, Jiang Liu, Shuai Zhang, Ling Chen, Jia-Zheng Lu, Ming-Qing Zhang
    World Journal of Gastrointestinal Endoscopy.2024; 16(8): 494.     CrossRef
Original Articles
Article image
Extremely well-differentiated adenocarcinoma of the stomach: diagnostic pitfalls in endoscopic biopsy
Jongwon Lee, In-Seob Lee, Ji Yong Ahn, Young Soo Park, Jihun Kim
J Pathol Transl Med. 2022;56(2):63-72.   Published online November 16, 2021
DOI: https://doi.org/10.4132/jptm.2021.10.12
  • 5,170 View
  • 418 Download
  • 3 Web of Science
  • 3 Crossref
AbstractAbstract PDFSupplementary Material
Background
Extremely well-differentiated adenocarcinoma (EWDA) is a deceptively bland-looking adenocarcinoma of the stomach. It often causes diagnostic problems, especially in endoscopic biopsy samples. To better recognize this deceptively bland lesion, we carefully reviewed a series of EWDAs treated at our institution.
Methods
A total of 55 specimens from 19 patients were obtained. Endoscopic, gross and microscopic features defining EWDA were described and documented. For comparison, hyperplastic polyp specimens were randomly selected and analyzed.
Results
Most cases (18 of 19, 94.7%) were advanced gastric cancer (AGC) and primarily located in the body of the stomach (15 of 19, 79.0%). The majority of AGCs were non-ulcerated (11 of 18, 61.1%) with an undermining growth pattern and a relatively small mucosal involvement. Specific histologic features included an irregular glandular shape, an undulating apical cytoplasmic border, disproportionately large glands, a variably distended mucinous cytoplasm. Classical features, such as small infiltrating glands or desmoplastic reactions, were barely observed. Identification of irregularly spaced nuclei and disruption of the foveolar epithelial structure, along with atypical features described above were helpful in making a diagnosis especially in gastric forceps biopsies.
Conclusions
Awareness of the histomorphologic characteristics described in this report would lead to timely diagnosis and prevent repeated endoscopic procedures.

Citations

Citations to this article as recorded by  
  • Unusual or Uncommon Histology of Gastric Cancer
    Jinho Shin, Young Soo Park
    Journal of Gastric Cancer.2024; 24(1): 69.     CrossRef
  • A case of gastric adenocarcinoma with pyloric gland-type infiltrating submucosa
    Kaiho Hirata, Shusuke Yagi, Hideki Miyazaki, Kazuhiko Yamada, Naoki Akazawa, Naoki Enomoto, Kyoko Nohara, Chizu Yokoi, Toru Igari, Norihiro Kokudo
    Surgical Case Reports.2024;[Epub]     CrossRef
  • Gastric-type extremely well-differentiated adenocarcinoma of the stomach: A rare tumor with diagnostic difficulties and high inter-observer variation in endoscopic pinch biopsies
    Soomin Ahn, Sujin Park, Hyun Hee Koh, Han Gyeol Kim, Hyunjin Kim, Jae Yeong Son, Boram Lee, Hyunwoo Lee, Soohyun Hwang, Junhun Cho, Yun Kyung Lee, Ryoji Kushima, Amitabh Srivastava, Kyoung-Mee Kim
    Pathology - Research and Practice.2024; 263: 155599.     CrossRef
Article image
Deep learning for computer-assisted diagnosis of hereditary diffuse gastric cancer
Sean A. Rasmussen, Thomas Arnason, Weei-Yuarn Huang
J Pathol Transl Med. 2021;55(2):118-124.   Published online January 22, 2021
DOI: https://doi.org/10.4132/jptm.2020.12.22
  • 3,172 View
  • 128 Download
  • 5 Web of Science
  • 5 Crossref
AbstractAbstract PDF
Background
Patients with hereditary diffuse gastric cancer often undergo prophylactic gastrectomy to minimize cancer risk. Because intramucosal poorly cohesive carcinomas in this setting are typically not grossly visible, many pathologists assess the entire gastrectomy specimen microscopically. With 150 or more slides per case, this is a major time burden for pathologists. This study utilizes deep learning methods to analyze digitized slides and detect regions of carcinoma.
Methods
Prophylactic gastrectomy specimens from seven patients with germline CDH1 mutations were analyzed (five for training/validation and two for testing, with a total of 133 tumor foci). All hematoxylin and eosin slides containing cancer foci were digitally scanned, and patches of size 256×256 pixels were randomly extracted from regions of cancer as well as from regions of normal background tissue, resulting in 15,851 images for training/validation and 970 images for testing. A model with DenseNet-169 architecture was trained for 150 epochs, then evaluated on images from the test set. External validation was conducted on 814 images scanned at an outside institution.
Results
On individual patches, the trained model achieved a receiver operating characteristic (ROC) area under the curve (AUC) of 0.9986. This enabled it to maintain a sensitivity of 90% with a false-positive rate of less than 0.1%. On the external validation dataset, the model achieved a similar ROC AUC of 0.9984. On whole slide images, the network detected 100% of tumor foci and correctly eliminated an average of 99.9% of the non-cancer slide area from consideration.
Conclusions
Overall, our model shows encouraging progress towards computer-assisted diagnosis of hereditary diffuse gastric cancer.

Citations

Citations to this article as recorded by  
  • Non-endoscopic Applications of Machine Learning in Gastric Cancer: A Systematic Review
    Marianne Linley L. Sy-Janairo, Jose Isagani B. Janairo
    Journal of Gastrointestinal Cancer.2024; 55(1): 47.     CrossRef
  • Artificial intelligence applicated in gastric cancer: A bibliometric and visual analysis via CiteSpace
    Guoyang Zhang, Jingjing Song, Zongfeng Feng, Wentao Zhao, Pan Huang, Li Liu, Yang Zhang, Xufeng Su, Yukang Wu, Yi Cao, Zhengrong Li, Zhigang Jie
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Deep learning of endoscopic features for the assessment of neoadjuvant therapy response in locally advanced rectal cancer
    Anqi Wang, Jieli Zhou, Gang Wang, Beibei Zhang, Hongyi Xin, Haiyang Zhou
    Asian Journal of Surgery.2023; 46(9): 3568.     CrossRef
  • Preparing Data for Artificial Intelligence in Pathology with Clinical-Grade Performance
    Yuanqing Yang, Kai Sun, Yanhua Gao, Kuansong Wang, Gang Yu
    Diagnostics.2023; 13(19): 3115.     CrossRef
  • Using Deep Learning to Predict Final HER2 Status in Invasive Breast Cancers That are Equivocal (2+) by Immunohistochemistry
    Sean A. Rasmussen, Valerie J. Taylor, Alexi P. Surette, Penny J. Barnes, Gillian C. Bethune
    Applied Immunohistochemistry & Molecular Morphology.2022; 30(10): 668.     CrossRef
Case Studies
Article image
Gastric crystal-storing histiocytosis with concomitant mucosa-associated lymphoid tissue lymphoma
Mee Joo, Nam-Hoon Kim
J Pathol Transl Med. 2020;54(4):332-335.   Published online May 22, 2020
DOI: https://doi.org/10.4132/jptm.2020.04.20
  • 4,067 View
  • 111 Download
  • 3 Web of Science
  • 3 Crossref
AbstractAbstract PDF
Crystal-storing histiocytosis (CSH) is a rare entity that is characterized by intrahistiocytic accumulation of crystallized immunoglobulins. CSH is not a malignant process per se, but the majority of CSH cases are associated with underlying lymphoproliferative disorder. Although CSH can occur in a variety of organs, gastric CSH is very rare. We present a localized gastric CSH with concomitant mucosaassociated lymphoid tissue (MALT) lymphoma, manifesting as an ulcer bleeding in a 56-year-old man. Histologically, the biopsied gastric mucosa demonstrated expansion of the lamina propria by prominent collections of large eosinophilic mononuclear cells containing fibrillary crystalloid inclusions. Immunohistochemical studies revealed that the crystal-storing cells were histiocytes harboring kappa light chain-restricted immunoglobulin crystals. Within the lesion, atypical centrocyte-like cells forming lymphoepithelial lesions were seen, consistent with MALT lymphoma. Since this entity is rare and unfamiliar, difficulties in diagnosis may arise. Particularly, in this case, the lymphomatous area was obscured by florid CSH, making the diagnosis more challenging.

Citations

Citations to this article as recorded by  
  • Crystal-storing histiocytosis in the stomach: A case report and review of the literature
    Linghong Kong, Liyan Xue, Yanfeng Zhong, Shenglan Wang, Danfeng Zheng, Lining Wang, Yang Jiao, Xinpeng Zhang, Huizhong Xue, Xiaogang Liu
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Lambda-Restricted Crystal-Storing Histiocytosis of Stomach: A Case Report and Review of Literature
    Nalini Bansal, Pankaj Puri, Nishant Nagpal, Rahul Naithani, Rahul Gupta
    Cureus.2021;[Epub]     CrossRef
  • Immunoglobulin-Storing Histiocytosis: A Case Based Systemic Review
    Hanne Wiese-Hansen, Friedemann Leh, Anette Lodvir Hemsing, Håkon Reikvam
    Journal of Clinical Medicine.2021; 10(9): 1834.     CrossRef
Article image
Gastric IgG4-related disease presenting as a mass lesion and masquerading as a gastrointestinal stromal tumor
Banumathi Ramakrishna, Rohan Yewale, Kavita Vijayakumar, Patta Radhakrishna, Balakrishnan Siddartha Ramakrishna
J Pathol Transl Med. 2020;54(3):258-262.   Published online March 4, 2020
DOI: https://doi.org/10.4132/jptm.2020.02.10
  • 5,251 View
  • 153 Download
  • 7 Web of Science
  • 8 Crossref
AbstractAbstract PDF
IgG4-related disease of the stomach is a rare disorder, and only a few cases have been reported. We present two cases that were identified over a 2-month period in our center. Two male patients aged 52 and 48 years presented with mass lesion in the stomach, which were clinically thought to be gastrointestinal stromal tumor, and they underwent excision of the lesion. Microscopic examination revealed marked fibrosis, which was storiform in one case, associated with diffuse lymphoplasmacytic infiltration and an increase in IgG4-positive plasma cells on immunohistochemistry. Serum IgG4 level was markedly elevated. Although rare, IgG4-related disease should be considered in the differential diagnosis of gastric submucosal mass lesions.

Citations

Citations to this article as recorded by  
  • Systemic diseases affecting the GI tract: A review of clinical and histopathologic manifestations
    Maryam K. Pezhouh, Dora Lam-Himlin, Atif Zaheer, Lysandra Voltaggio
    Annals of Diagnostic Pathology.2024; 73: 152351.     CrossRef
  • Utilizing Immunoglobulin G4 Immunohistochemistry for Risk Stratification in Patients with Papillary Thyroid Carcinoma Associated with Hashimoto Thyroiditis
    Faridul Haq, Gyeongsin Park, Sora Jeon, Mitsuyoshi Hirokawa, Chan Kwon Jung
    Endocrinology and Metabolism.2024; 39(3): 468.     CrossRef
  • Isolated IgG4-related disease of terminal ileum: Report of a rare case and review of literature
    Subham Bhowmik, Hemanga K. Bhattacharjee, Joyner Abraham, Raju Sharma, Prasenjit Das
    Journal of Cancer Research and Therapeutics.2024;[Epub]     CrossRef
  • Great Mimics in Oncology: A Retrospective Study from a Tertiary Care Centre of Eastern India
    Suvendu Maji, Jayesh kumar Jha, Vikram Chaturvedi
    Indian Journal of Surgical Oncology.2024;[Epub]     CrossRef
  • CGB5, INHBA and TRAJ19 Hold Prognostic Potential as Immune Genes for Patients with Gastric Cancer
    Bei Ji, Lili Qiao, Wei Zhai
    Digestive Diseases and Sciences.2023; 68(3): 791.     CrossRef
  • IgG4-related diseases of the digestive tract
    J.-Matthias Löhr, Miroslav Vujasinovic, Jonas Rosendahl, John H. Stone, Ulrich Beuers
    Nature Reviews Gastroenterology & Hepatology.2022; 19(3): 185.     CrossRef
  • Clinicopathological characteristics of gastric IgG4‐related disease: Systematic scoping review
    Haruki Sawada, Torrey Czech, Krixie Silangcruz, Landon Kozai, Adham Obeidat, Eric Andrew Wien, Midori Filiz Nishimura, Asami Nishikori, Yasuharu Sato, Yoshito Nishimura
    Journal of Gastroenterology and Hepatology.2022; 37(10): 1865.     CrossRef
  • Utility of gastric biopsy in diagnosing IgG4‐related gastrointestinal disease
    Kaori Uchino, Kenji Notohara, Takeshi Uehara, Yasuhiro Kuraishi, Junya Itakura, Akihiro Matsukawa
    Pathology International.2021; 71(2): 124.     CrossRef
Review
Article image
Tumor immune response and immunotherapy in gastric cancer
Yoonjin Kwak, An Na Seo, Hee Eun Lee, Hye Seung Lee
J Pathol Transl Med. 2020;54(1):20-33.   Published online November 1, 2019
DOI: https://doi.org/10.4132/jptm.2019.10.08
  • 13,817 View
  • 738 Download
  • 61 Web of Science
  • 57 Crossref
AbstractAbstract PDF
Remarkable developments in immuno-oncology have changed the landscape of gastric cancer (GC) treatment. Because immunotherapy intervenes with tumor immune response rather than directly targeting tumor cells, it is important to develop a greater understanding of tumor immunity. This review paper summarizes the tumor immune reaction and immune escape mechanisms while focusing on the role of T cells and their co-inhibitory signals, such as the immune checkpoint molecules programmed death-1 and programmed deathligand 1 (PD-L1). This paper also describes past clinical trials of immunotherapy for patients with GC and details their clinical implications. Strong predictive markers are essential to improve response to immunotherapy. Microsatellite instability, Epstein-Barr virus, PD-L1 expression, and tumor mutational burden are now regarded as potent predictive markers for immunotherapy in patients with GC. Novel immunotherapy and combination therapy targeting new immune checkpoint molecules such as lymphocyte-activation gene 3, T cell immunoglobulin, and mucin domain containing-3, and indoleamine 2,3-dioxygenase have been suggested, and trials are ongoing to evaluate their safety and efficacy. Immunotherapy is an important treatment option for patients with GC and has great potential for improving patient outcome, and further research in immuno-oncology should be carried out.

Citations

Citations to this article as recorded by  
  • Ubiquilin-4 induces immune escape in gastric cancer by activating the notch signaling pathway
    Quan Jiang, Hao Chen, Shixin Zhou, Tao Zhu, Wenshuai Liu, Hao Wu, Yong Zhang, Fenglin Liu, Yihong Sun
    Cellular Oncology.2024; 47(1): 303.     CrossRef
  • Expression and prognostic value of APOBEC2 in gastric adenocarcinoma and its association with tumor-infiltrating immune cells
    Lipan Wei, Xiuqian Wu, Lan Wang, Ling Chen, Xuejun Wu, Tiantian Song, Yuanyuan Wang, Wenjun Chang, Aizhen Guo, Yongdong Niu, Haihua Huang
    BMC Cancer.2024;[Epub]     CrossRef
  • Identification and characterization of CLEC11A and its derived immune signature in gastric cancer
    Qing Zheng, Zhenqi Gong, Baizhi Li, Runzi Cheng, Weican Luo, Cong Huang, Huaiming Wang
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • Cervical cancer subtype identification and model building based on lipid metabolism and post-infection microenvironment immune landscape
    Yongzhi Chen, Rongjie Cui, Dun Xiong, Yuan Zhao, Jianyu Pang, Samina Gul, Qi Qi, Yuheng Tang, Xuhong Zhou, Wenru Tang
    Heliyon.2024; 10(9): e30746.     CrossRef
  • Systematic Analysis of Tumor Stem Cell-related Gene Characteristics to Predict the PD-L1 Immunotherapy and Prognosis of Gastric Cancer
    Chenchen Wang, Ying Chen, Ru Zhou, Ya’nan Yang, Yantian Fang
    Current Medicinal Chemistry.2024; 31(17): 2467.     CrossRef
  • Comprehensive landscape of m6A regulator-related gene patterns and tumor microenvironment infiltration characterization in gastric cancer
    Bin Peng, Yinglin Lin, Gao Yi, Mingzhen Lin, Yao Xiao, Yezhenghong Qiu, Wenxia Yao, Xinke Zhou, Zhaoyu Liu
    Scientific Reports.2024;[Epub]     CrossRef
  • Distinctive Phenotypic and Microenvironmental Characteristics of Neuroendocrine Carcinoma and Adenocarcinoma Components in Gastric Mixed Adenoneuroendocrine Carcinoma
    Yoonjin Kwak, Soo Kyung Nam, Yujun Park, Yun-Suhk Suh, Sang-Hoon Ahn, Seong-Ho Kong, Do Joong Park, Hyuk-Joon Lee, Hyung-Ho Kim, Han-Kwang Yang, Hye Seung Lee
    Modern Pathology.2024; 37(10): 100568.     CrossRef
  • FOXP3+/CD8+ ratio associated with aggressive behavior in RUNX3‐methylated diffuse esophagogastric junction tumor
    Suguru Maruyama, Yu Imamura, Tasuku Toihata, Ikumi Haraguchi, Manabu Takamatsu, Makiko Yamashita, Yuichiro Nakashima, Eiji Oki, Kenichi Taguchi, Manabu Yamamoto, Shinji Mine, Akihiko Okamura, Jun Kanamori, Souya Nunobe, Takeshi Sano, Shigehisa Kitano, Tet
    Cancer Science.2024;[Epub]     CrossRef
  • Computed tomography-detected extramural venous invasion-related gene signature: a potential negative biomarker of immune checkpoint inhibitor treatment in patients with gastric cancer
    Hao Yang, Xinyi Gou, Caizhen Feng, Yinli Zhang, Fan Chai, Nan Hong, Yingjiang Ye, Yi Wang, Bo Gao, Jin Cheng
    Journal of Translational Medicine.2023;[Epub]     CrossRef
  • A standardized pathology report for gastric cancer: 2nd edition
    Young Soo Park, Myeong-Cherl Kook, Baek-hui Kim, Hye Seung Lee, Dong-Wook Kang, Mi-Jin Gu, Ok Ran Shin, Younghee Choi, Wonae Lee, Hyunki Kim, In Hye Song, Kyoung-Mee Kim, Hee Sung Kim, Guhyun Kang, Do Youn Park, So-Young Jin, Joon Mee Kim, Yoon Jung Choi,
    Journal of Pathology and Translational Medicine.2023; 57(1): 1.     CrossRef
  • A Standardized Pathology Report for Gastric Cancer: 2nd Edition
    Young Soo Park, Myeong-Cherl Kook, Baek-hui Kim, Hye Seung Lee, Dong-Wook Kang, Mi-Jin Gu, Ok Ran Shin, Younghee Choi, Wonae Lee, Hyunki Kim, In Hye Song, Kyoung-Mee Kim, Hee Sung Kim, Guhyun Kang, Do Youn Park, So-Young Jin, Joon Mee Kim, Yoon Jung Choi,
    Journal of Gastric Cancer.2023; 23(1): 107.     CrossRef
  • Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach
    Tae-Han Kim, In-Ho Kim, Seung Joo Kang, Miyoung Choi, Baek-Hui Kim, Bang Wool Eom, Bum Jun Kim, Byung-Hoon Min, Chang In Choi, Cheol Min Shin, Chung Hyun Tae, Chung sik Gong, Dong Jin Kim, Arthur Eung-Hyuck Cho, Eun Jeong Gong, Geum Jong Song, Hyeon-Su Im
    Journal of Gastric Cancer.2023; 23(1): 3.     CrossRef
  • Could Toll-like Receptor 2 Serve as Biomarker to Detect Advanced Gastric Cancer?
    Marek Majewski, Kamil Torres, Paulina Mertowska, Sebastian Mertowski, Izabela Korona-Głowniak, Jan Korulczyk, Witold Zgodziński, Ewelina Grywalska
    International Journal of Molecular Sciences.2023; 24(6): 5824.     CrossRef
  • Research Progress of Immunotherapy for Gastric Cancer
    Zhipeng Zhang, Ningning Liu, Mingyu Sun
    Technology in Cancer Research & Treatment.2023;[Epub]     CrossRef
  • Case Report: A rare synchronous multiple gastric carcinoma achieved progression-free disease through NGS-guided serial treatment
    Xinyi Shao, Jin Yin, Di Wang, Erjiong Huang, Yini Zhang, Jiani C. Yin, Chen Huang, Hao Wu, Xiaoli Wu
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Artificial Intelligence-Enabled Gastric Cancer Interpretations
    Mustafa Yousif, Liron Pantanowitz
    Surgical Pathology Clinics.2023; 16(4): 673.     CrossRef
  • The Optimal Tumor Mutational Burden Cutoff Value as a Novel Marker for Predicting the Efficacy of Programmed Cell Death-1 Checkpoint Inhibitors in Advanced Gastric Cancer
    Jae Yeon Jang, Youngkyung Jeon, Sun Young Jeong, Sung Hee Lim, Won Ki Kang, Jeeyun Lee, Seung Tae Kim
    Journal of Gastric Cancer.2023; 23(3): 476.     CrossRef
  • Biomarkers for Predicting Response to Personalized Immunotherapy in Gastric Cancer
    Moonsik Kim, Ji Yun Jeong, An Na Seo
    Diagnostics.2023; 13(17): 2782.     CrossRef
  • The Prognostic Value of the Prognostic Nutritional Index in Patients with Advanced or Metastatic Gastric Cancer Treated with Immunotherapy
    Yuting Pan, Yue Ma, Guanghai Dai
    Nutrients.2023; 15(19): 4290.     CrossRef
  • Molecular classification of gastric cancer predicts survival in patients undergoing radical gastrectomy based on project HOPE
    Kenichiro Furukawa, Keiichi Hatakeyama, Masanori Terashima, Takeshi Nagashima, Kenichi Urakami, Keiichi Ohshima, Akifumi Notsu, Takashi Sugino, Taisuke Yagi, Keiichi Fujiya, Satoshi Kamiya, Makoto Hikage, Yutaka Tanizawa, Etsuro Bando, Yae Kanai, Yasuto A
    Gastric Cancer.2022; 25(1): 138.     CrossRef
  • Immunotherapy for Gastric Cancer: A 2021 Update
    Christo Kole, Nikolaos Charalampakis, Sergios Tsakatikas, Nikolaos-Iasonas Kouris, George Papaxoinis, Michalis V Karamouzis, Anna Koumarianou, Dimitrios Schizas
    Immunotherapy.2022; 14(1): 41.     CrossRef
  • The immune microenvironment in gastric adenocarcinoma
    Yana Zavros, Juanita L. Merchant
    Nature Reviews Gastroenterology & Hepatology.2022; 19(7): 451.     CrossRef
  • Immunomodulation by Gut Microbiome on Gastrointestinal Cancers: Focusing on Colorectal Cancer
    Raghad Khalid AL-Ishaq, Lenka Koklesova, Peter Kubatka, Dietrich Büsselberg
    Cancers.2022; 14(9): 2140.     CrossRef
  • An Immunity-Associated lncRNA Signature for Predicting Prognosis in Gastric Adenocarcinoma
    Xiaowen Zhao, Pingfan Wu, Dongling Liu, Changtian Li, Ling Xue, Zhe Liu, Meng Zhu, Jie Yang, Ziyi Chen, Yaling Li, Yali She, Kathiravan Srinivasan
    Journal of Healthcare Engineering.2022; 2022: 1.     CrossRef
  • RNA modification writers influence tumor microenvironment in gastric cancer and prospects of targeted drug therapy
    Peng Song, Sheng Zhou, Xiaoyang Qi, Yuwen Jiao, Yu Gong, Jie Zhao, Haojun Yang, Zhifen Qian, Jun Qian, Liming Tang
    Journal of Bioinformatics and Computational Biology.2022;[Epub]     CrossRef
  • Identification of the three subtypes and the prognostic characteristics of stomach adenocarcinoma: analysis of the hypoxia-related long non-coding RNAs
    Zehua Fan, Yanqun Wang, Rong Niu
    Functional & Integrative Genomics.2022; 22(5): 919.     CrossRef
  • Complete Response of High Microsatellite Instability Gastric Cancer and Synchronous Microsatellite Stability Rectal Cancer
    Zachary E Hunzeker, Pooja Bhakta, Sindusha R Gudipally, Sri Bharathi Kavuri, Rohit Venkatesan, Chukwuyejulumafor Nwanze
    Cureus.2022;[Epub]     CrossRef
  • Immune Profiling in Gastric Cancer Reveals the Dynamic Landscape of Immune Signature Underlying Tumor Progression
    Yuhan Wei, Jianwei Zhang, Xueke Fan, Zhi Zheng, Xiaoyue Jiang, Dexi Chen, Yuting Lu, Yingrui Li, Miao Wang, Min Hu, Qi Du, Liuting Yang, Hongzhong Li, Yi Xiao, Yongfu Li, Jiangtao Jin, Deying Wang, Xiangliang Yuan, Qin Li
    Frontiers in Immunology.2022;[Epub]     CrossRef
  • Tumor vessel normalization and immunotherapy in gastric cancer
    Xianzhe Yu, Shan He, Jian Shen, Qiushi Huang, Peng Yang, Lin Huang, Dan Pu, Li Wang, Lu Li, Jinghua Liu, Zelong Liu, Lingling Zhu
    Therapeutic Advances in Medical Oncology.2022;[Epub]     CrossRef
  • FN1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancers
    Han Wang, Junchang Zhang, Huan Li, Hong Yu, Songyao Chen, Shuhao Liu, Changhua Zhang, Yulong He
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Molecular Pathology of Gastric Cancer
    Moonsik Kim, An Na Seo
    Journal of Gastric Cancer.2022; 22(4): 264.     CrossRef
  • Bioinformatics Analysis and Structure of Gastric Cancer Prognosis Model Based on Lipid Metabolism and Immune Microenvironment
    Yongzhi Chen, Hongjun Yuan, Qian Yu, Jianyu Pang, Miaomiao Sheng, Wenru Tang
    Genes.2022; 13(9): 1581.     CrossRef
  • Clinical implications of interleukins-31, 32, and 33 in gastric cancer
    Qing-Hua Liu, Ji-Wei Zhang, Lei Xia, Steven G Wise, Brett David Hambly, Kun Tao, Shi-San Bao
    World Journal of Gastrointestinal Oncology.2022; 14(9): 1808.     CrossRef
  • Microbiota and the Immune System—Actors in the Gastric Cancer Story
    Marek Majewski, Paulina Mertowska, Sebastian Mertowski, Konrad Smolak, Ewelina Grywalska, Kamil Torres
    Cancers.2022; 14(15): 3832.     CrossRef
  • Bioinformatics and Experimental Analyses Reveal MAP4K4 as a Potential Marker for Gastric Cancer
    Junping Zhang, Xiaoping Cai, Weifeng Cui, Zheng Wei
    Genes.2022; 13(10): 1786.     CrossRef
  • Common strategies for effective immunotherapy of gastroesophageal cancers using immune checkpoint inhibitors
    Shuang Ma, Fei Chen
    Pathology - Research and Practice.2022; 238: 154110.     CrossRef
  • High-level of intratumoral GITR+ CD4 T cells associate with poor prognosis in gastric cancer
    Shouyu Ke, Feng Xie, Yixian Guo, Jieqiong Chen, Zeyu Wang, Yimeng Yu, Haigang Geng, Danhua Xu, Xu Liu, Xiang Xia, Fengrong Yu, Chunchao Zhu, Zizhen Zhang, Gang Zhao, Bin Li, Wenyi Zhao
    iScience.2022; 25(12): 105529.     CrossRef
  • Characteristics of Adenosine-to-Inosine RNA editing-based subtypes and novel risk score for the prognosis and drug sensitivity in stomach adenocarcinoma
    Jingjing Pan, Xinyuan Gu, Jing Luo, Xinye Qian, Qiang Gao, Tianjie Li, Longying Ye, Chenlu Li
    Frontiers in Cell and Developmental Biology.2022;[Epub]     CrossRef
  • Inhibition of NF‐κB is required for oleanolic acid to downregulate PD‐L1 by promoting DNA demethylation in gastric cancer cells
    Xirong Lu, Yuyi Li, Wei Yang, Minghao Tao, Yanmiao Dai, Jinkang Xu, Qianfei Xu
    Journal of Biochemical and Molecular Toxicology.2021;[Epub]     CrossRef
  • Prognostic Value of C-Reactive Protein to Albumin Ratio in Gastric Cancer: A Meta-Analysis
    Liang Yue, Yi Lu, Yulin Li, Yilin Wang
    Nutrition and Cancer.2021; 73(10): 1864.     CrossRef
  • Immunogenic characteristics of microsatellite instability‐low esophagogastric junction adenocarcinoma based on clinicopathological, molecular, immunological and survival analyses
    Yu Imamura, Tasuku Toihata, Ikumi Haraguchi, Yoko Ogata, Manabu Takamatsu, Aya Kuchiba, Norio Tanaka, Osamu Gotoh, Seiichi Mori, Yuichiro Nakashima, Eiji Oki, Masaki Mori, Yoshinao Oda, Kenichi Taguchi, Manabu Yamamoto, Masaru Morita, Naoya Yoshida, Hideo
    International Journal of Cancer.2021; 148(5): 1260.     CrossRef
  • Two Similar Signatures for Predicting the Prognosis and Immunotherapy Efficacy of Stomach Adenocarcinoma Patients
    Taohua Yue, Shuai Zuo, Jing Zhu, Shihao Guo, Zhihao Huang, Jichang Li, Xin Wang, Yucun Liu, Shanwen Chen, Pengyuan Wang
    Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
  • Tumor microenvironment characterization in stage IV gastric cancer
    Feng Yang, Zhenbao Wang, Xianxue Zhang
    Bioscience Reports.2021;[Epub]     CrossRef
  • E2F2 inhibition induces autophagy via the PI3K/Akt/mTOR pathway in gastric cancer
    Hui Li, Shufen Zhao, Liwei Shen, Peige Wang, Shihai Liu, Yingji Ma, Zhiwei Liang, Gongjun Wang, Jing Lv, Wensheng Qiu
    Aging.2021; 13(10): 13626.     CrossRef
  • Chemoradiation induces upregulation of immunogenic cell death-related molecules together with increased expression of PD-L1 and galectin-9 in gastric cancer
    S. H. Petersen, L. F. Kua, S. Nakajima, W. P. Yong, K. Kono
    Scientific Reports.2021;[Epub]     CrossRef
  • Establishment of an Immune Cell Infiltration Score to Help Predict the Prognosis and Chemotherapy Responsiveness of Gastric Cancer Patients
    Quan Jiang, Jie Sun, Hao Chen, Chen Ding, Zhaoqing Tang, Yuanyuan Ruan, Fenglin Liu, Yihong Sun
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Microsatellite instability in Gastric Cancer: Between lights and shadows
    Elisabetta Puliga, Simona Corso, Filippo Pietrantonio, Silvia Giordano
    Cancer Treatment Reviews.2021; 95: 102175.     CrossRef
  • Survival-associated alternative splicing events interact with the immune microenvironment in stomach adenocarcinoma
    Zai-Sheng Ye, Miao Zheng, Qin-Ying Liu, Yi Zeng, Sheng-Hong Wei, Yi Wang, Zhi-Tao Lin, Chen Shu, Qiu-Hong Zheng, Lu-Chuan Chen
    World Journal of Gastroenterology.2021; 27(21): 2871.     CrossRef
  • Immunotherapy of gastric cancer: Past, future perspective and challenges
    Jun Xie, Liping Fu, Li Jin
    Pathology - Research and Practice.2021; 218: 153322.     CrossRef
  • Clinicopathologic and Prognostic Association of GRP94 Expression in Colorectal Cancer with Synchronous and Metachronous Metastases
    Sumi Yun, Sukmook Lee, Ho-Young Lee, Hyeon Jeong Oh, Yoonjin Kwak, Hye Seung Lee
    International Journal of Molecular Sciences.2021; 22(13): 7042.     CrossRef
  • Injectable shear-thinning polylysine hydrogels for localized immunotherapy of gastric cancer through repolarization of tumor-associated macrophages
    Yan Yang, Yang Yang, Meili Chen, Jianquan Chen, Jinyan Wang, Yajun Ma, Hanqing Qian
    Biomaterials Science.2021; 9(19): 6597.     CrossRef
  • Correlation between LRP1B Mutations and Tumor Mutation Burden in Gastric Cancer
    Sizhe Hu, Xiaokang Zhao, Feng Qian, Cancan Jin, Kaishun Hou, Tao Huang
    Computational and Mathematical Methods in Medicine.2021; 2021: 1.     CrossRef
  • Comprehensive Analysis to Identify MAGEA3 Expression Correlated With Immune Infiltrates and Lymph Node Metastasis in Gastric Cancer
    Jinji Jin, Jianxin Tu, Jiahuan Ren, Yiqi Cai, Wenjing Chen, Lifang Zhang, Qiyu Zhang, Guanbao Zhu
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Effect of P2X7 receptor on tumorigenesis and its pharmacological properties
    Wen-jun Zhang, Ce-gui Hu, Zheng-ming Zhu, Hong-liang Luo
    Biomedicine & Pharmacotherapy.2020; 125: 109844.     CrossRef
  • Current status and future potential of predictive biomarkers for immune checkpoint inhibitors in gastric cancer
    Byung Woog Kang, Ian Chau
    ESMO Open.2020; 5(4): e000791.     CrossRef
  • Is Ramucirumab Still the Only Second-Line Treatment in Metastatic Gastric Cancer?
    Khalil El Gharib, Hampig Raphael Kourie
    Pharmacogenomics.2020; 21(17): 1203.     CrossRef
  • Deep Learning Predicts Underlying Features on Pathology Images with Therapeutic Relevance for Breast and Gastric Cancer
    Renan Valieris, Lucas Amaro, Cynthia Aparecida Bueno de Toledo Osório, Adriana Passos Bueno, Rafael Andres Rosales Mitrowsky, Dirce Maria Carraro, Diana Noronha Nunes, Emmanuel Dias-Neto, Israel Tojal da Silva
    Cancers.2020; 12(12): 3687.     CrossRef
Case Study
Multiple Neuroendocrine Tumors in Stomach and Duodenum in a Multiple Endocrine Neoplasia Type 1 Patient
Bohyun Kim, Han-Kwang Yang, Woo Ho Kim
J Pathol Transl Med. 2018;52(2):126-129.   Published online December 21, 2017
DOI: https://doi.org/10.4132/jptm.2017.09.16
  • 6,770 View
  • 144 Download
  • 1 Web of Science
  • 1 Crossref
AbstractAbstract PDF
A 67-year-old woman with a history of subtotal parathyroidectomy, distal pancreatectomy, and total splenectomy 23 years prior underwent surgical gastric resection for neuroendocrine tumors of the stomach and duodenum. Meticulous examination of the entire stomach and duodenum revealed multiple scattered, minute neuroendocrine tumors. To the best of our knowledge, this is the first case report of a patient diagnosed with gastroduodenal neuroendocrine tumors associated with multiple endocrine neoplasia type 1 (MEN 1) in whom complete histologic mapping of the whole gastrectomy specimen was performed. The presence of MEN 1–associated neuroendocrine tumors in the stomach is very rare, but should be considered in patients diagnosed with MEN 1 who present with a new tumor in the stomach.

Citations

Citations to this article as recorded by  
  • A Case of Asymptomatic Multiple Endocrine Neoplasia Type I with Thymic Carcinoid
    Suk Ki Park, Moon Won Lee, In Sub Han, Young Joo Park, Sung Yong Han, Joon Woo Park, Bong Eun Lee, Gwang Ha Kim, Sang Soo Kim
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2019; 19(1): 65.     CrossRef
Original Articles
Extramural Perineural Invasion in pT3 and pT4 Gastric Carcinomas
Alejandro España-Ferrufino, Leonardo S. Lino-Silva, Rosa A. Salcedo-Hernández
J Pathol Transl Med. 2018;52(2):79-84.   Published online November 9, 2017
DOI: https://doi.org/10.4132/jptm.2017.11.01
  • 7,652 View
  • 141 Download
  • 9 Web of Science
  • 8 Crossref
AbstractAbstract PDF
Background
Perineural invasion (PNI) is widely studied in malignant tumors, and its prognostic significance is well demonstrated. Most studies have focused on evaluating the mural PNI (mPNI); however, extramural PNI (ePNI) may influence the prognosis in gastric cancer. We evaluated the prognostic value of ePNI compared with mPNI in gastric cancer in this observational comparative cross-sectional study.
Methods
Seventy-three pT3 and pT4 gastric carcinomas with PNI were evaluated. Forty-eight (65.7%) were in the mPNI group and the remaining in the ePNI group.
Results
Clinicopathologic characteristics between the two groups were similar, except for the outcomes. The 5-year disease-specific survival (DSS) rate was 64% for the mPNI group and 50% for the ePNI group (p=.039), a difference that did not remain significant in multivariate analysis. The only independent adverse prognostic factor in multivariate analysis was the presence of lymph node metastasis (hazard ratio, 1.757; 95% confidence interval, 1.082 to 2.854; p=.023).
Conclusions
We demonstrated the prognostic effect of ePNI for DSS in surgically resected pT3–pT4 gastric cancer patients. ePNI could be considered in the staging and prognostic systems of gastric cancer to stratify patients with a high risk of recurrence.

Citations

Citations to this article as recorded by  
  • Neural control of tumor immunity
    Burak Kizil, Francesco De Virgiliis, Christoph Scheiermann
    The FEBS Journal.2024; 291(21): 4670.     CrossRef
  • Spectral CT-based nomogram for preoperative prediction of perineural invasion in locally advanced gastric cancer: a prospective study
    Jing Li, Shuning Xu, Yi Wang, Mengjie Fang, Fei Ma, Chunmiao Xu, Hailiang Li
    European Radiology.2023; 33(7): 5172.     CrossRef
  • Crosstalk between cancer cells and the nervous system
    Meng Huang, Gu Gong, Yicheng Deng, Xinmiao Long, Wenyong Long, Qing Liu, Wei Zhao, Rufu Chen
    Medicine Advances.2023; 1(3): 173.     CrossRef
  • Targeting tumor innervation: premises, promises, and challenges
    Xinyu Li, Xueqiang Peng, Shuo Yang, Shibo Wei, Qing Fan, Jingang Liu, Liang Yang, Hangyu Li
    Cell Death Discovery.2022;[Epub]     CrossRef
  • Cancer-Associated Neurogenesis and Nerve-Cancer Cross-talk
    Deborah A. Silverman, Vena K. Martinez, Patrick M. Dougherty, Jeffrey N. Myers, George A. Calin, Moran Amit
    Cancer Research.2021; 81(6): 1431.     CrossRef
  • Perineural Invasion and Postoperative Adjuvant Chemotherapy Efficacy in Patients With Gastric Cancer
    Qing Tao, Wen Zhu, Xiaohui Zhao, Mei Li, Yongqian Shu, Deqiang Wang, Xiaoqin Li
    Frontiers in Oncology.2020;[Epub]     CrossRef
  • Perineural invasion as a predictive factor for survival outcome in gastric cancer patients: a systematic review and meta-analysis
    Bochao Zhao, Wu Lv, Di Mei, Rui Luo, Shiyang Bao, Baojun Huang, Jie Lin
    Journal of Clinical Pathology.2020; 73(9): 544.     CrossRef
  • Consensus-Expressed CXCL8 and MMP9 Identified by Meta-Analyzed Perineural Invasion Gene Signature in Gastric Cancer Microarray Data
    Xiuzhi Jia, Minjia Lu, Chen Rui, Ying Xiao
    Frontiers in Genetics.2019;[Epub]     CrossRef
HER2 Status and Its Heterogeneity in Gastric Carcinoma of Vietnamese Patient
Dang Anh Thu Phan, Vu Thien Nguyen, Thi Ngoc Ha Hua, Quoc Dat Ngo, Thi Phuong Thao Doan, Sao Trung Nguyen, Anh Tu Thai, Van Thanh Nguyen
J Pathol Transl Med. 2017;51(4):396-402.   Published online June 19, 2017
DOI: https://doi.org/10.4132/jptm.2017.04.24
  • 8,455 View
  • 148 Download
  • 8 Web of Science
  • 7 Crossref
AbstractAbstract PDF
Background
Human epidermal growth factor receptor 2 (HER2) is related to the pathogenesis and poor outcome of numerous types of carcinomas, including gastric carcinoma. Gastric cancer patients with HER2 positivity have become potential candidates for targeted therapy with trastuzumab.
Methods
We investigated 208 gastric cancer specimens using immunohistochemistry (IHC), fluorescence in situ hybridization and dual in situ hybridization (ISH). We also investigated the concordance between IHC and ISH. The correlation between HER2 status and various clinicopathological findings was also investigated.
Results
In total, 15.9% (33/208) and 24.5% (51/208) of gastric cancers showed HER2 gene amplification and protein overexpression, respectively. A high level of concordance between ISH and IHC analyses (91.3%, κ = 0.76) was found. A significant correlation between HER2 status and intestinal-type (p < .05) and differentiated carcinomas (p < .05) was also noted. The HER2 heterogeneity was high in gastric cancers; we found 68.8% phenotypic heterogeneity and 57.6% genotypic heterogeneity. Heterogeneity in HER2 protein expression and gene amplification showed a close association with diffuse histologic type and IHC 2+.
Conclusions
HER2 protein overexpression and gene amplification were detected in 24.5% and 15.9% of gastric cancer specimens, respectively. Intestinal-type showed a higher level of HER2 protein overexpression and gene amplification than diffuse type. HER2 status also showed a significant relationship with well- and moderately-differentiated carcinomas. The ratio of phenotypic and genotypic heterogeneity of HER2 was high in gastric carcinomas and was associated with HER2 IHC 2+ and diffuse histologic type.

Citations

Citations to this article as recorded by  
  • Identifying HER2 from serum‐derived exosomes in advanced gastric cancer as a promising biomarker for assessing tissue HER2 status and predicting the efficacy of trastuzumab‐based therapy
    Qian Li, Minzhi Lv, Lihua Lv, Nida Cao, Aiguang Zhao, Jiayan Chen, Xi Tang, Rongkui Luo, Shan Yu, Yan Zhou, Yuehong Cui, Wei Guo, Tianshu Liu
    Cancer Medicine.2023; 12(4): 4110.     CrossRef
  • A study of human epidermal growth factor receptor 2 overexpression by immunohistochemistry in patients with gastric adenocarcinoma
    Rafid A. Abood, Saad Alomar, Sawsan S. Alharoon
    Journal of Public Health in Africa.2023; 14(9): 4.     CrossRef
  • Receptor Tyrosine Kinases Amplified in Diffuse-Type Gastric Carcinoma: Potential Targeted Therapies and Novel Downstream Effectors
    Hideki Yamaguchi, Yuko Nagamura, Makoto Miyazaki
    Cancers.2022; 14(15): 3750.     CrossRef
  • Cell differentiation trajectory predicts patient potential immunotherapy response and prognosis in gastric cancer
    Renshen Xiang, Yuping Rong, Yuhang Ge, Wei Song, Jun Ren, Tao Fu
    Aging.2021; 13(4): 5928.     CrossRef
  • Identification of stem cell-related subtypes and risk scoring for gastric cancer based on stem genomic profiling
    Renshen Xiang, Wei Song, Jun Ren, Jing Wu, Jincheng Fu, Tao Fu
    Stem Cell Research & Therapy.2021;[Epub]     CrossRef
  • Oncogenic signaling pathways associated with immune evasion and resistance to immune checkpoint inhibitors in cancer
    Yoshie Kobayashi, Seung-Oe Lim, Hirohito Yamaguchi
    Seminars in Cancer Biology.2020; 65: 51.     CrossRef
  • Blockade of ITGA2 Induces Apoptosis and Inhibits Cell Migration in Gastric Cancer
    Yu-Chang Chuang, Hsin-Yi Wu, Yu-Ling Lin, Shey-Cherng Tzou, Cheng-Hsun Chuang, Ting-Yan Jian, Pin-Rong Chen, Yuan-Ching Chang, Chi-Hsin Lin, Tse-Hung Huang, Chao-Ching Wang, Yi-Lin Chan, Kuang-Wen Liao
    Biological Procedures Online.2018;[Epub]     CrossRef
Review
Rare Gastric Lesions Associated with Helicobacter pylori Infection: A Histopathological Review
Mee Joo
J Pathol Transl Med. 2017;51(4):341-351.   Published online June 5, 2017
DOI: https://doi.org/10.4132/jptm.2017.04.03
  • 11,486 View
  • 341 Download
  • 14 Web of Science
  • 13 Crossref
AbstractAbstract PDF
Helicobacter pylori infection is associated with chronic gastritis, peptic ulcer disease, gastric adenocarcinoma, and mucosa-associated lymphoid tissue lymphoma. However, some rare gastric lesions exhibiting distinctive histological features may also be associated with H. pylori infection, including lymphocytic gastritis, granulomatous gastritis, Russell body gastritis, or crystal-storing histiocytosis. Although diverse factors can contribute to their development, there is convincing evidence that H. pylori infection may play a pathogenic role. These findings are mainly based on studies in patients with these lesions who exhibited clinical and histological improvements after H. pylori eradication therapy. Thus, H. pylori eradication therapy might be indicated in patients with no other underlying disease, particularly in countries with a high prevalence of H. pylori infection. This review describes the characteristic histological features of these rare lesions and evaluates the evidence regarding a causative role for H. pylori infection in their pathogenesis.

Citations

Citations to this article as recorded by  
  • Rapid diagnosis and precision treatment of Helicobacter pylori infection in clinical settings
    Zeeshan Umar, Jia-Wei Tang, Barry J. Marshall, Alfred Chin Yen Tay, Liang Wang
    Critical Reviews in Microbiology.2024; : 1.     CrossRef
  • Crystal-Storing Histiocytosis: The Iceberg of More Serious Conditions
    Mousa Mobarki, Alexandra Papoudou-Bai, Jean Marc Dumollard, Abdulaziz H. Alhazmi, Shaqraa Musawi, Mohammed Ali Madkhali, Khalid Y. Muqri, Michel Péoc’h, Georgia Karpathiou
    Diagnostics.2023; 13(2): 271.     CrossRef
  • Acute systemic infection-associated Russell body gastroesophagitis: A case report and literature review
    Elizaveta Flerova, Susan Inniss, Nneamaka Nwaoduah, Richard P. Denicola, Jialing Huang
    Human Pathology Reports.2023; 31: 300696.     CrossRef
  • Infectious Gastric Diseases Other than Helicobacter
    Hyemin Jo, Cheol Min Shin
    The Korean Journal of Gastroenterology.2023; 82(6): 269.     CrossRef
  • H. pylori Infection and Virulence Factors cagA and vacA (s and m Regions) in Gastric Adenocarcinoma from Pará State, Brazil
    Igor Brasil-Costa, Cintya de Oliveira Souza, Leni Célia Reis Monteiro, Maria Elisabete Silva Santos, Edivaldo Herculano Correa De Oliveira, Rommel Mario Rodriguez Burbano
    Pathogens.2022; 11(4): 414.     CrossRef
  • Crystal-storing histiocytosis in the stomach: A case report and review of the literature
    Linghong Kong, Liyan Xue, Yanfeng Zhong, Shenglan Wang, Danfeng Zheng, Lining Wang, Yang Jiao, Xinpeng Zhang, Huizhong Xue, Xiaogang Liu
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Dynamics of inflammatory changes of the gastric mucosa in children with duodenal ulcer
    T.V. Sorokman, P.M. Moldovan, L.Yu. Khlunovska, I.Ya. Lozyuk
    CHILD`S HEALTH.2022; 16(4): 285.     CrossRef
  • Clinicopathological characteristics and aetiological factors of granulomatous gastritis
    Yuanxin Liang, Shengjie Cui, Alexandros D Polydorides
    Histopathology.2021; 79(6): 1040.     CrossRef
  • A case of Russell body gastritis with multifocal lesions
    Michinobu Umakoshi, Ken Miyabe, Hajime Ishii, Yukitsugu Kudo-Asabe, Yukinobu Ito, Makoto Yoshida, Daichi Maeda, Masato Sageshima, Akiteru Goto
    SAGE Open Medical Case Reports.2020;[Epub]     CrossRef
  • Gastric crystal-storing histiocytosis with concomitant mucosa-associated lymphoid tissue lymphoma
    Mee Joo, Nam-Hoon Kim
    Journal of Pathology and Translational Medicine.2020; 54(4): 332.     CrossRef
  • Nonimmunoglobulin Crystal-Storing Histiocytosis (CSH): Case Report and Literature Review
    Manuel Beltran, Sharad Khurana, Yennifer Gil, Jason T. Lewis, Rohit Kumar, James M. Foran, Masayuki Nagasawa
    Case Reports in Hematology.2020; 2020: 1.     CrossRef
  • Benign and malignant gastroduodenal diseases associated with Helicobacter pylori: a narrative review and personal remarks in 2018
    György M. Buzás
    Minerva Gastroenterologica e Dietologica.2018;[Epub]     CrossRef
  • Crystal-storing Histiocytosis in the Stomach
    Christina A. Arnold, Wendy L. Frankel, Ling Guo, Chandra Krishnan, Sheryl Pfeil, Melinda Schumacher, Lysandra Voltaggio, Martha M. Yearsley, Wei Chen
    American Journal of Surgical Pathology.2018; 42(10): 1317.     CrossRef
Case Study
Perivascular Epithelioid Cell Tumor in the Stomach
Sun Ah Shin, Jiwoon Choi, Kyung Chul Moon, Woo Ho Kim
J Pathol Transl Med. 2017;51(4):428-432.   Published online April 4, 2017
DOI: https://doi.org/10.4132/jptm.2016.09.16
  • 7,744 View
  • 140 Download
  • 4 Web of Science
  • 3 Crossref
AbstractAbstract PDF
Perivascular epithelioid cell tumors or PEComas can arise in any location in the body. However, a limited number of cases of gastric PEComa have been reported. We present two cases of gastric PEComas. The first case involved a 62-year-old woman who presented with a 4.2 cm gastric subepithelial mass in the prepyloric antrum, and the second case involved a 67-year-old man with a 5.0 cm mass slightly below the gastroesophageal junction. Microscopic examination revealed that both tumors were composed of perivascular epithelioid cells that were immunoreactive for melanocytic and smooth muscle markers. Prior to surgery, the clinical impression of both tumors was gastrointestinal stromal tumor (GIST), and the second case was erroneously diagnosed as GIST even after microscopic examination. Although gastric PEComa is a very rare neoplasm, it should be considered in the differential diagnosis of gastric submucosal lesions.

Citations

Citations to this article as recorded by  
  • Unusual paediatric sigmoid perivascular epithelioid cell tumour with regional lymph node metastasis treated using gemcitabine and docetaxel: a case report and literature review
    Hsiu-Chung Cheng, Chia-Yu Kuo, Ching-Wen Huang, Hsiang-Hung Shih, Chih-Hung Lin, Jaw-Yuan Wang
    Journal of International Medical Research.2021;[Epub]     CrossRef
  • Gastric Perivascular Epithelioid Cell Tumor (PEComa)
    Jinghong Xu, Yu Yan, Xueping Xiang, Peter Jiang, Xiangrong Hu, Wenjun Yang
    American Journal of Clinical Pathology.2019; 152(2): 221.     CrossRef
  • Robotic wedge resection of a rare gastric perivascular epithelioid cell tumor: A case report
    Alessandra Marano, Francesca Maione, Yanghee Woo, Luca Pellegrino, Paolo Geretto, Diego Sasia, Mirella Fortunato, Giulio Fraternali Orcioni, Roberto Priotto, Renato Fasoli, Felice Borghi
    World Journal of Clinical Cases.2019; 7(23): 4011.     CrossRef
Review
Molecular Dimensions of Gastric Cancer: Translational and Clinical Perspectives
Yoon Young Choi, Sung Hoon Noh, Jae-Ho Cheong
J Pathol Transl Med. 2016;50(1):1-9.   Published online October 26, 2015
DOI: https://doi.org/10.4132/jptm.2015.09.10
  • 12,467 View
  • 153 Download
  • 20 Web of Science
  • 20 Crossref
AbstractAbstract PDF
Gastric cancer is a global health burden and has the highest incidence in East Asia. This disease is complex in nature because it arises from multiple interactions of genetic, local environmental, and host factors, resulting in biological heterogeneity. This genetic intricacy converges on molecular characteristics reflecting the pathophysiology, tumor biology, and clinical outcome. Therefore, understanding the molecular characteristics at a genomic level is pivotal to improving the clinical care of patients with gastric cancer. A recent landmark study, The Cancer Genome Atlas (TCGA) project, showed the molecular landscape of gastric cancer through a comprehensive molecular evaluation of 295 primary gastric cancers. The proposed molecular classification divided gastric cancer into four subtypes: Epstein-Barr virus–positive, microsatellite unstable, genomic stable, and chromosomal instability. This information will be taken into account in future clinical trials and will be translated into clinical therapeutic decisions. To fully realize the clinical benefit, many challenges must be overcome. Rapid growth of high-throughput biology and functional validation of molecular targets will further deepen our knowledge of molecular dimensions of this cancer, allowing for personalized precision medicine.

Citations

Citations to this article as recorded by  
  • Advancements and challenges in gastric cancer: epidemiology, biomarkers, and therapeutic strategies
    Marina Nishimuni, Laura Carolina Lopez Claro, Maria Ignez Freitas Melro Braghiroli
    Surgical and Experimental Pathology.2024;[Epub]     CrossRef
  • Research Progress of MSI Gastric Cancer Subtypes
    成菊 马
    Advances in Clinical Medicine.2022; 12(07): 6719.     CrossRef
  • OCT4-mediated transcription confers oncogenic advantage for a subset of gastric tumors with poor clinical outcome
    Jaishree Pandian, Ponmathi Panneerpandian, Balaji T. Sekar, Karthikeyan Selvarasu, Kumaresan Ganesan
    Functional & Integrative Genomics.2022; 22(6): 1345.     CrossRef
  • Secondary Primary Cancer after Primary Gastric Cancer: Literature Review and Big Data Analysis Using the Health Insurance Review and Assessment Service (HIRA) Database of Republic of Korea
    Jeong Ho Song, Yeonkyoung Lee, Jaesung Heo, Sang-Yong Son, Hoon Hur, Sang-Uk Han
    Cancers.2022; 14(24): 6165.     CrossRef
  • Microsatellite instability: a review of what the oncologist should know
    Kai Li, Haiqing Luo, Lianfang Huang, Hui Luo, Xiao Zhu
    Cancer Cell International.2020;[Epub]     CrossRef
  • Single Patient Classifier Assay, Microsatellite Instability, and Epstein-Barr Virus Status Predict Clinical Outcomes in Stage II/III Gastric Cancer: Results from CLASSIC Trial
    Chul Kyu Roh, Yoon Young Choi, Seohee Choi, Won Jun Seo, Minah Cho, Eunji Jang, Taeil Son, Hyoung-Il Kim, Hyeseon Kim, Woo Jin Hyung, Yong-Min Huh, Sung Hoon Noh, Jae-Ho Cheong
    Yonsei Medical Journal.2019; 60(2): 132.     CrossRef
  • Ten Thousand Consecutive Gastrectomies for Gastric Cancer: Perspectives of a Master Surgeon
    Yoon Young Choi, Minah Cho, In Gyu Kwon, Taeil Son, Hyoung-Il Kim, Seung Ho Choi, Jae-Ho Cheong, Woo Jin Hyung
    Yonsei Medical Journal.2019; 60(3): 235.     CrossRef
  • Clinicopathologic significance of human leukocyte antigen class I expression in patients with stage II and III gastric cancer
    Yujun Park, Jiwon Koh, Yoonjin Kwak, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Woo Ho Kim, Hye Seung Lee
    Cancer Immunology, Immunotherapy.2019; 68(11): 1779.     CrossRef
  • Phosphoproteomics Enables Molecular Subtyping and Nomination of Kinase Candidates for Individual Patients of Diffuse-Type Gastric Cancer
    Mengsha Tong, Chunyu Yu, Jinwen Shi, Wenwen Huang, Sai Ge, Mingwei Liu, Lei Song, Dongdong Zhan, Xia Xia, Wanlin Liu, Jinwen Feng, Wenhao Shi, Jiafu Ji, Jing Gao, Tieliu Shi, Weimin Zhu, Chen Ding, Yi Wang, Fuchu He, Lin Shen, Tingting Li, Jun Qin
    iScience.2019; 22: 44.     CrossRef
  • Trastuzumab Specific Epitope Evaluation as a Predictive and Prognostic Biomarker in Gastric Cancer Patients
    Jiwon Koh, Soo Kyung Nam, Youn Woo Lee, Jin Won Kim, Keun-Wook Lee, Chan-Young Ock, Do-Youn Oh, Sang-Hoon Ahn, Hyung-Ho Kim, Keon-Wook Kang, Woo Ho Kim, Ho-Young Lee, Hye Seung Lee
    Biomolecules.2019; 9(12): 782.     CrossRef
  • Targeted drug delivery of capecitabine to mice xenograft gastric cancer by PAMAM dendrimer nanocarrier
    Sharareh Jafari, Fatemeh Nabavizadeh, Jalal Vahedian, Mehdi Shafie Ardestani, Hedayat Samandari, Ali Zare Mehrjerdi
    african journal of gastroenterology and hepatology.2019; 2(1): 28.     CrossRef
  • New therapeutic options opened by the molecular classification of gastric cancer
    Mihaela Chivu-Economescu, Lilia Matei, Laura G Necula, Denisa L Dragu, Coralia Bleotu, Carmen C Diaconu
    World Journal of Gastroenterology.2018; 24(18): 1942.     CrossRef
  • Proposed Molecular and miRNA Classification of Gastric Cancer
    Lara Alessandrini, Melissa Manchi, Valli De Re, Riccardo Dolcetti, Vincenzo Canzonieri
    International Journal of Molecular Sciences.2018; 19(6): 1683.     CrossRef
  • High serum MMP-14 predicts worse survival in gastric cancer
    Aaro Kasurinen, Taina Tervahartiala, Alli Laitinen, Arto Kokkola, Timo Sorsa, Camilla Böckelman, Caj Haglund, Dajun Deng
    PLOS ONE.2018; 13(12): e0208800.     CrossRef
  • miR-30 functions as an oncomiR in gastric cancer cells through regulation of P53-mediated mitochondrial apoptotic pathway
    Jianjun Wang, Yang Jiao, Lunmeng Cui, Lili Jiang
    Bioscience, Biotechnology, and Biochemistry.2017; 81(1): 119.     CrossRef
  • Clinicopathologic implication of meticulous pathologic examination of regional lymph nodes in gastric cancer patients
    Jiwon Koh, Hee Eun Lee, Woo Ho Kim, Hye Seung Lee, Ju-Seog Lee
    PLOS ONE.2017; 12(3): e0174814.     CrossRef
  • Perioperative chemotherapy for resectable gastric cancer – what is the evidence?
    Erling A Bringeland, Hans H Wasmuth, Jon E Grønbech
    Scandinavian Journal of Gastroenterology.2017; 52(6-7): 647.     CrossRef
  • Molecular classifications of gastric cancers: Novel insights and possible future applications
    Silvio Ken Garattini, Debora Basile, Monica Cattaneo, Valentina Fanotto, Elena Ongaro, Marta Bonotto, Francesca V Negri, Rosa Berenato, Paola Ermacora, Giovanni Gerardo Cardellino, Mariella Giovannoni, Nicoletta Pella, Mario Scartozzi, Lorenzo Antonuzzo,
    World Journal of Gastrointestinal Oncology.2017; 9(5): 194.     CrossRef
  • GRAM domain-containing protein 1B (GRAMD1B), a novel component of the JAK/STAT signaling pathway, functions in gastric carcinogenesis
    Puja Khanna, Pei Jou Chua, Belinda Shu Ee Wong, Changhong Yin, Aye Aye Thike, Wei Keat Wan, Puay Hoon Tan, Gyeong Hun Baeg
    Oncotarget.2017; 8(70): 115370.     CrossRef
  • Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients
    Jiwon Koh, Chan-Young Ock, Jin Won Kim, Soo Kyung Nam, Yoonjin Kwak, Sumi Yun, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Woo Ho Kim, Hye Seung Lee
    Oncotarget.2017; 8(16): 26356.     CrossRef
Case Studies
IgG4-Related Disease Presented as a Mural Mass in the Stomach
Chang Gok Woo, Jeong Hwan Yook, Ah Young Kim, Jihun Kim
J Pathol Transl Med. 2016;50(1):67-70.   Published online September 30, 2015
DOI: https://doi.org/10.4132/jptm.2015.07.28
  • 8,480 View
  • 87 Download
  • 21 Web of Science
  • 21 Crossref
AbstractAbstract PDF
Isolated gastric IgG4-related disease (IgG4-RD) is a very rare tumefactive inflammatory condition, with only a few cases reported to date. A 48-year-old woman was incidentally found to have a subepithelial tumor in the stomach. Given a presumptive diagnosis of gastrointestinal stromal tumor or neuroendocrine tumor, she underwent wedge resection. The lesion was vaguely nodular and mainly involved the submucosa and proper muscle layer. Microscopically, all classical features of type I autoimmune pancreatitis including lymphoplasmacytic infiltration, storiform fibrosis, obliterative phlebitis, and numerous IgG4-positive plasma cells were seen. She had no evidence of IgG4-RD in other organs. Although very rare, IgG4-RD should be considered one of the differential diagnoses in the setting of gastric wall thickening or subepithelial mass-like lesion. Deep biopsy with awareness of this entity might avoid unnecessary surgical intervention.

Citations

Citations to this article as recorded by  
  • Value of High‐Frequency Ultrasonography in the Qualitative and Semi‐Quantitative Assessment of Immunoglobulin G4‐Related Submandibular Sialadenitis
    Lei Chen, Lin Nong, Jumei Liu, Luzeng Chen, Yuhong Shao, Xiuming Sun
    Journal of Ultrasound in Medicine.2023; 42(10): 2235.     CrossRef
  • IgG4-related pseudotumours: a series of 12 cases and a review of the literature
    Andrea Maccagno, Bianca Grosser, László Füzesi, Björn Konukiewitz, Dmytro Vlasenko, Dorothea Weckermann, Stephan Raab, Johannes Zenk, Abbas Agaimy, Bruno Märkl
    Pathology.2022; 54(5): 563.     CrossRef
  • IgG4-Related Disease With Gastrointestinal Involvement: Case Reports and Literature Review
    Xinhe Zhang, Xing Jin, Lin Guan, Xuyong Lin, Xuedan Li, Yiling Li
    Frontiers in Immunology.2022;[Epub]     CrossRef
  • Clinicopathological characteristics of gastric IgG4‐related disease: Systematic scoping review
    Haruki Sawada, Torrey Czech, Krixie Silangcruz, Landon Kozai, Adham Obeidat, Eric Andrew Wien, Midori Filiz Nishimura, Asami Nishikori, Yasuharu Sato, Yoshito Nishimura
    Journal of Gastroenterology and Hepatology.2022; 37(10): 1865.     CrossRef
  • Utility of gastric biopsy in diagnosing IgG4‐related gastrointestinal disease
    Kaori Uchino, Kenji Notohara, Takeshi Uehara, Yasuhiro Kuraishi, Junya Itakura, Akihiro Matsukawa
    Pathology International.2021; 71(2): 124.     CrossRef
  • A reappraisal of sclerosing nodular and/or polypoid lesions of the gastrointestinal tract rich in IgG4‐positive plasma cells
    Runjan Chetty
    Histopathology.2020; 76(6): 832.     CrossRef
  • Gastric IgG4-related disease presenting as a mass lesion and masquerading as a gastrointestinal stromal tumor
    Banumathi Ramakrishna, Rohan Yewale, Kavita Vijayakumar, Patta Radhakrishna, Balakrishnan Siddartha Ramakrishna
    Journal of Pathology and Translational Medicine.2020; 54(3): 258.     CrossRef
  • IgG4-related Sclerosing Disease Forming a Gastric Submucosal Tumor Diagnosed after Laparoscopic Endoscopic Cooperative Surgery—Report of a Case—
    Tatsuki ISHIKAWA, Katsunori NAKANO, Masafumi OSAKA, Yayoi KADOTANI, Kaori OKUGAWA, Kiyokazu AKIOKA, Kenta SHIGEMORI, Yohei HOSOKAWA
    Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association).2020; 81(2): 254.     CrossRef
  • Calcifying fibrous tumor of the gastrointestinal tract: A clinicopathologic review and update
    Donald Turbiville, Xu-Chen Zhang
    World Journal of Gastroenterology.2020; 26(37): 5597.     CrossRef
  • A Suspected Case of IgG4-Related Appendiceal Pseudotumor
    Yudai Hojo, Yoshiharu Shirakata, Ai Izumi, Jun Matsui, Tokuyuki Yamashita, Hikaru Aoki, Makoto Kurimoto, Masaaki Hirata, Naoki Goda, Hiroaki Ito, Jun Tamura
    The Japanese Journal of Gastroenterological Surgery.2020; 53(12): 976.     CrossRef
  • Immunoglobulin G4-related gastric pseudotumor – An impostor: Case report
    Manuel Santiago Mosquera, Andrea Suarez Gómez, Hugo Herrera, Karen Moreno-Medina, Alejandro González-Orozco, Carlos J-Perez Rivera
    International Journal of Surgery Case Reports.2020; 75: 333.     CrossRef
  • Imaging and pathological features of gastric lesion of immunoglobulin G4-related disease: A case report and review of the recent literature
    Dai Inoue, Norihide Yoneda, Kotaro Yoshida, Hiromi Nuka, Jun Kinoshita, Sachio Fushida, Fumihito Toshima, Tetsuya Minami, Masayuki Takahira, Shoko Hamaoka, Hiroko Ikeda, Toshifumi Gabata, Mitsuhiro Kawano
    Modern Rheumatology.2019; 29(2): 377.     CrossRef
  • Immunoglobulin G4-Related Gastric Ulcer Mimicking Advanced Stomach Cancer in a Patient with Type I Autoimmune Pancreatitis
    Joung Ha Park, Jin Hee Noh, Jang ho Lee, Goeun Lee, Seung-Mo Hong, Kwang Bum Cho, Myung-Hwan Kim
    The Korean Journal of Medicine.2019; 94(3): 287.     CrossRef
  • Review of IgG4-related disease
    Raquel Sánchez-Oro, Elsa María Alonso-Muñoz, Lidia Martí Romero
    Gastroenterología y Hepatología (English Edition).2019; 42(10): 638.     CrossRef
  • Revisión de la enfermedad relacionada con la IgG4
    Raquel Sánchez-Oro, Elsa María Alonso-Muñoz, Lidia Martí Romero
    Gastroenterología y Hepatología.2019; 42(10): 638.     CrossRef
  • Gastrointestinal manifestation of immunoglobulin G4-related disease: clarification through a multicenter survey
    Kenji Notohara, Terumi Kamisawa, Kazushige Uchida, Yoh Zen, Mitsuhiro Kawano, Satomi Kasashima, Yasuharu Sato, Masahiro Shiokawa, Takeshi Uehara, Hajime Yoshifuji, Hiroko Hayashi, Koichi Inoue, Keisuke Iwasaki, Hiroo Kawano, Hiroyuki Matsubayashi, Yukitos
    Journal of Gastroenterology.2018; 53(7): 845.     CrossRef
  • IgG4-Related Disease Mimicking Crohn’s Disease: A Case Report and Review of Literature
    Fabiana Ciccone, Antonio Ciccone, Mirko Di Ruscio, Filippo Vernia, Gianluca Cipolloni, Gino Coletti, Giuseppe Calvisi, Giuseppe Frieri, Giovanni Latella
    Digestive Diseases and Sciences.2018; 63(4): 1072.     CrossRef
  • IgG4-related Disease in the Stomach which Was Confused with Gastrointestinal Stromal Tumor (GIST): Two Case Reports and Review of the Literature
    Ho Seok Seo, Yoon Ju Jung, Cho Hyun Park, Kyo Young Song, Eun Sun Jung
    Journal of Gastric Cancer.2018; 18(1): 99.     CrossRef
  • Multivisceral IgG4-related disease presenting as recurrent massive gastrointestinal bleeding: a case report and literature review
    Xuexue Deng, Ronghua Fang, Jianshu Zhang, Rongqiong Li
    BMC Gastroenterology.2018;[Epub]     CrossRef
  • IgG4-Related Sclerosing Disease Presenting as a Gastric Submucosal Tumor
    Takashi Masuda, Toshifumi Matsumoto, Yushi Kaishakuji, Hirotada Tajiri, Akinori Egashira, Hirofumi Kawanaka
    The Japanese Journal of Gastroenterological Surgery.2018; 51(10): 599.     CrossRef
  • A rare case of IgG4-related disease: a gastric mass, associated with regional lymphadenopathy
    Dimitar Bulanov, Elena Arabadzhieva, Sasho Bonev, Atanas Yonkov, Diana Kyoseva, Tihomir Dikov, Violeta Dimitrova
    BMC Surgery.2016;[Epub]     CrossRef
Gastric-Type Extremely Well-Differentiated Adenocarcinoma of the Stomach: A Challenge for Preoperative Diagnosis
Mee Joo, Song Hee Han
J Pathol Transl Med. 2016;50(1):71-74.   Published online September 30, 2015
DOI: https://doi.org/10.4132/jptm.2015.07.14
  • 10,850 View
  • 158 Download
  • 10 Web of Science
  • 10 Crossref
AbstractAbstract PDF
Gastric-type extremely well-differentiated adenocarcinoma (EWDA) is a rare type of gastric adenocarcinoma characterized by infiltration of well-formed mucinous glands with little or no nuclear atypia, which resemble foveolar epithelium or pyloric glands. Because of its high degree of differentiation, preoperative biopsy diagnosis of gastric-type EWDA is very difficult. We encountered a case of gastric-type EWDA, manifesting as a Borrmann type 4 lesion, in a 47-year-old man. Despite four repeated biopsies, the preoperative biopsy diagnosis was not conclusive due to the scarcity of diagnostic tumor cells and lack of knowledge regarding the unusual histologic findings of gastric-type EWDA. We herein describe the histologic findings of gastric-type EWDA in detail, with the aim of facilitating a preoperative biopsy diagnosis and understanding of this rare type of gastric adenocarcinoma.

Citations

Citations to this article as recorded by  
  • Unusual or Uncommon Histology of Gastric Cancer
    Jinho Shin, Young Soo Park
    Journal of Gastric Cancer.2024; 24(1): 69.     CrossRef
  • Clinical pathological characteristics of “crawling-type” gastric adenocarcinoma cancer: A case report
    Yong-Wei Xu, Yan Song, Jun Tian, Ba-Cui Zhang, Yu-Sheng Yang, Jing Wang
    World Journal of Gastrointestinal Oncology.2024; 16(4): 1660.     CrossRef
  • Gastric-type extremely well-differentiated adenocarcinoma of the stomach: A rare tumor with diagnostic difficulties and high inter-observer variation in endoscopic pinch biopsies
    Soomin Ahn, Sujin Park, Hyun Hee Koh, Han Gyeol Kim, Hyunjin Kim, Jae Yeong Son, Boram Lee, Hyunwoo Lee, Soohyun Hwang, Junhun Cho, Yun Kyung Lee, Ryoji Kushima, Amitabh Srivastava, Kyoung-Mee Kim
    Pathology - Research and Practice.2024; 263: 155599.     CrossRef
  • Clinicopathological features of gastric adenocarcinoma of fundic gland type
    Bao-Zhen Guo, Zhen-Zhen Liu, Gao-Fei Shen, Fei Zhu, Hui-Fen Lian, Xin Li, Jun-Yi Zheng, Jin-Peng Li, Shui-Miao Deng, Rui Huang
    World Chinese Journal of Digestology.2023; 31(6): 244.     CrossRef
  • Characterization of pathological stomach tissue using polarization-sensitive second harmonic generation microscopy
    Hwanhee Jeon, MacAulay Harvey, Richard Cisek, Elisha Bennett, Danielle Tokarz
    Biomedical Optics Express.2023; 14(10): 5376.     CrossRef
  • Extremely well-differentiated adenocarcinoma of the stomach: diagnostic pitfalls in endoscopic biopsy
    Jongwon Lee, In-Seob Lee, Ji Yong Ahn, Young Soo Park, Jihun Kim
    Journal of Pathology and Translational Medicine.2022; 56(2): 63.     CrossRef
  • Helicobacter pylori-negative Gastric Cancer
    Sun-Young Lee
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2021; 21(1): 10.     CrossRef
  • Preoperative diagnosis of a gastric extremely well-differentiated adenocarcinoma: A case report
    Katsushi Suenaga, Shiro Matsumoto, Alan Kawarai Lefor, Yoshimasa Miura, Yoshinori Hosoya, Daigo Kuboki, Hidenori Haruta, Kentaro Kurashina, Atsushi Kihara, Daisuke Matsubara, Yasunari Sakuma, Joji Kitayama, Naohiro Sata
    International Journal of Surgery Case Reports.2020; 73: 319.     CrossRef
  • Gastric adenocarcinoma of the fundic gland type: clinicopathological features of eight patients treated with endoscopic submucosal dissection
    Chengfang Li, Xinglong Wu, Shuang Yang, Xiaorong Yang, Jin Yao, Hong Zheng
    Diagnostic Pathology.2020;[Epub]     CrossRef
  • Gastric Adenocarcinoma of the Fundic Gland Type
    Mark A Benedict, Gregory Y Lauwers, Dhanpat Jain
    American Journal of Clinical Pathology.2018; 149(6): 461.     CrossRef

J Pathol Transl Med : Journal of Pathology and Translational Medicine
TOP